Business
Why the Incannex Healthcare (ASX:IHL) share price is up 15% today
The Incannex Healthcare Limited (ASX: IHL) share price has hit a 5-year high at 29 cents during early trade. The shares have since retreated back to 26 cents, up 18%.
All the excitement comes after the company released an announcement this morning pertaining to an ongoing research program.
Positive results prompting further research
Incannex Healthcare is a pharmaceutical development company utilising medicinal cannabis and psychedelics to generate treatments for a range of disorders and diseases. In today’s update, Incannex discussed the positive results of using its proprietary anti-inflammatory IHL-675A in treating inflammatory bowel disease (IBD).
The company’s IHL-675A treatment is a combination of cannabidiol ‘CBD’…
-
Noosa News22 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News16 hours agoHelp to make recycling stick
-
Noosa News14 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business16 hours agoAlphabet’s stock looks like a brilliant buy right now